The Gruber Foundation has awarded Douglas Wallace its 2012 Genetics Prize for his contributions to mitochondrial genetics and disease. He will receive the $500,000 prize in November at the annual meeting of the American Society of Human Genetics.
Wallace is the director of the Center for Mitochondrial and Epigenomic Medicine at the Children's Hospital of Philadelphia as well as a professor of pathology and laboratory medicine at the Perelman School of Medicine at the University of Pennsylvania. Previously, he held academic positions at Stanford University, Emory University, and the University of California, Irvine.
Wallace was the first to identify that mitochondrial DNA is inherited solely through the mother. He also identified the first mitochondrial disease, Leber's hereditary optic neuropathy, and linked mtDNA mutations to a wide range of clinical symptoms, including deafness, neuropsychiatric disorders, cardiac and muscle problems, and metabolic diseases such as diabetes.
Knome has appointed Heidi Rehm to its scientific advisory board. She is a board-certified clinical geneticist who is currently chief laboratory director of the Laboratory for Molecular Medicine at Partners HealthCare Center for Personalized Genetic Medicine and also an assistant professor of pathology and director of the Clinical Molecular Genetics Training Program at Harvard Medical School.
She holds a PhD in genetics from Harvard University.
Edison Liu has been elected to the Foundation for the National Institutes of Health's board of directors. His term began on June 19.
Liu is the president and CEO of the Jackson Laboratory and president of the Human Genome Organization. He joined the Jackson Laboratory from the Genome Institute of Singapore, where he was the founding executive director. Prior to that, he was the scientific director of the National Cancer Institute's division of clinical sciences.